Searching News Database: rhenium
HSMN NewsFeed - 18 Sep 2023
MiRus(R) Announces Launch of Molybdenum-Rhenium Low Profile ATLAS(TM) MoRe(R) Foot and Ankle Plating System
MiRus(R) Announces Launch of Molybdenum-Rhenium Low Profile ATLAS(TM) MoRe(R) Foot and Ankle Plating System
HSMN NewsFeed - 8 Mar 2012
ICON Interventional Systems Receives CE Mark for the Nuloy(R) Coronary Stent System
ICON Interventional Systems Receives CE Mark for the Nuloy(R) Coronary Stent System
HSMN NewsFeed - 3 Jun 2007
Xanthus Announces Phase 1 Results for P2045 - a Targeted Agent for Non-Small Cell Lung Cancer
Xanthus Announces Phase 1 Results for P2045 - a Targeted Agent for Non-Small Cell Lung Cancer
HSMN NewsFeed - 6 Sep 2006
Xanthus Pharmaceuticals Licenses Novel Cancer Targeting Agents From Schering AG, Berlin
Xanthus Pharmaceuticals Licenses Novel Cancer Targeting Agents From Schering AG, Berlin
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!